Article info

Download PDFPDF
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
  1. Correspondence to:
    Dr O Sitbon
    Centre des Maladies Vasculaires Pulmonaires, Hôpital Antoine Béclère, Université Paris-Sud, 157 rue de la Porte de Trivaux, 92141 Clamart, France; olivier.sitbonabc.aphp.fr
View Full Text

Citation

Sitbon O, McLaughlin VV, Badesch DB, et al
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Publication history

  • Received January 19, 2005
  • Accepted July 3, 2005
  • First published July 29, 2005.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.